Control of Innate Lymphoid Cells and Intestinal Homeostasis by Neurotrophic Factors.

Inheritance of inflamed microbiota confers increased susceptibility to colitis.

Potential of Parasite Products to Suppress Inflammatory Bowel Disease.

Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.

Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.

Gastric Control of Intestinal Function.

Synthetic Engineering of Enhanced Fitness and Adhesion Properties in Probiotics for the treatment of Inflammatory Bowel Disease.

Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.

Potential of Parasite Products to Suppress Inflammatory Bowel Disease.

Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.